Too speculative. They lose money.
Stock price when the opinion was issued
As of Nov 03, 2026. Market Open.
Up 152% last year. They got FDA approval for one of their top drugs last year to treat a lung condition. It pulled back 18% last month due to a disappointing trial result in a drug. Worth watching this.
Build your watch list
Sign in to track investmentsyou care about
Liberty International Investment Management Inc
CNBC
ETF Capital Management Inc.
Rule Investment Media
Stockchase
Too speculative. They lose money.